Semin Respir Crit Care Med 2010; 31(1): 087-096
DOI: 10.1055/s-0029-1246284
© Thieme Medical Publishers

Liberation and Animation: Strategies to Minimize Brain Dysfunction in Critically Ill Patients

Matthew S. King1 , Marta L. Render2 , Eugene Wesley Ely1 , Paula L. Watson1
  • 1Department of Pulmonology and Critical Care, Vanderbilt Medical Center, Nashville, Tennessee
  • 2Division of Pulmonary, Critical Care, and Sleep Medicine, Cincinnati VA Medical Center, Cincinnati, Ohio
Further Information

Publication History

Publication Date:
25 January 2010 (online)

ABSTRACT

Acute brain dysfunction, usually manifested as delirium, occurs in up to 80% of critically ill patients. Delirium increases costs of hospitalizations and affects short-term outcomes such as duration of mechanical ventilation, intensive care unit (ICU) length of stay, and the hospital length of stay. Long-term consequences—cognitive impairment and increased risk of death—can be devastating. For adequate recognition and management it is imperative to implement a successful delirium monitoring and assessment strategy. A liberation and animation strategy can reduce both the incidence and the duration of delirium. Liberation aims to reduce the harmful effects of sedative exposure through use of target-based sedation protocols, spontaneous awakening trials, and proper choice of sedative as well as liberation from the ventilator and the ICU. Animation refers to early mobilization, which reduces delirium and improves neurocognitive outcomes. Delirium is a serious problem with important consequences and can be prevented or improved using the information that we have learned in the last decade.

REFERENCES

  • 1 Porter K A. Pale Horse, Pale Rider. Orlando, FL; Harcourt 1936
  • 2 Barrough P. The Methode of Phisicke, Conteyning the Causes, Signs, and Cures of Inward Diseases in Mans Body from the Head to the Foote. London; Vautrollier 1583
  • 3 Rusch B. Medical Inquiries and Observations upon the Diseases of the Mind. Philadelphia; Kimber & Richardson 1812
  • 4 Bergeron N, Dubois M-J, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool.  Intensive Care Med. 2001;  27 859-864
  • 5 Ely E W, Margolin R, Francis J et al.. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).  Crit Care Med. 2001;  29 1370-1379
  • 6 Morandi A, Pandharipande P, Trabucchi M et al.. Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients.  Intensive Care Med. 2008;  34 1907-1915
  • 7 Ely E W, Shintani A, Truman B et al.. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.  JAMA. 2004;  291 1753-1762
  • 8 Milbrandt E B, Deppen S, Harrison P L et al.. Costs associated with delirium in mechanically ventilated patients.  Crit Care Med. 2004;  32 955-962
  • 9 Halpern N A, Pastores S M. Critical care medicine in the United States 2000–2005: an analysis of bed numbers, occupancy rates, payer mix, and costs.  Crit Care Med. 2005;  , 2009 Aug 27. [Epub ahead of print]
  • 10 Jackson J C, Gordon S M, Hart R P, Hopkins R O, Ely E W. The association between delirium and cognitive decline: a review of the empirical literature.  Neuropsychol Rev. 2004;  14 87-98
  • 11 Dubois M J, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors.  Intensive Care Med. 2001;  27 1297-1304
  • 12 Ely E W, Gautam S, Margolin R et al.. The impact of delirium in the intensive care unit on hospital length of stay.  Intensive Care Med. 2001;  27 1892-1900
  • 13 MacLullich A M, Beaglehole A, Hall R J, Meagher D J. Delirium and long-term cognitive impairment.  Int Rev Psychiatry. 2009;  21 30-42
  • 14 Hopkins R O, Weaver L K, Pope D, Orme J F, Bigler E D, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome.  Am J Respir Crit Care Med. 1999;  160 50-56
  • 15 Rothenhausler H B, Ehrentraut S, Stoll C, Schelling G, Kapfhammer H P. The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study.  Gen Hosp Psychiatry. 2001;  23 90-96
  • 16 Angus D C, Carlet J. 2002 Brussels Roundtable Participants . Surviving intensive care: a report from the 2002 Brussels Roundtable.  Intensive Care Med. 2003;  29 368-377
  • 17 Hopkins R O, Gale S D, Weaver L K. Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome.  Brain Inj. 2006;  20 263-271
  • 18 Girard T D, Jackson J C, Pandharipande P P, Thompson J L, Shintani A K, Ely E W. Duration of delirium as a predictor of long-term cognitive impairment in survivors of critical illness [abstract].  Am J Respir Crit Care Med. 2009;  179 A5477
  • 19 McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E. Delirium predicts 12-month mortality.  Arch Intern Med. 2002;  162 457-463
  • 20 Lin S M, Liu C Y, Wang C H et al.. The impact of delirium on the survival of mechanically ventilated patients.  Crit Care Med. 2004;  32 2254-2259
  • 21 Ouimet S, Kavanagh B P, Gottfried S B, Skrobik Y. Incidence, risk factors and consequences of ICU delirium.  Intensive Care Med. 2007;  33 66-73
  • 22 Pisani M A, Kong S Y, Kasl S V, Murphy T E, Araujo K L, Van Ness P H. Days of delirium are associated with 1-year mortality in an older intensive care unit population.  Am J Respir Crit Care Med. 2009 Sep 10. [Epub ahead of print]; 
  • 23 Pandharipande P, Cotton B A, Shintani A et al.. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients.  J Trauma. 2008;  65 34-41
  • 24 Pandharipande P, Shintani A, Peterson J et al.. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.  Anesthesiology. 2006;  104 21-26
  • 25 Sessler C N, Gosnell M S, Grap M J et al.. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients.  Am J Respir Crit Care Med. 2002;  166 1338-1344
  • 26 Ramsay M A, Savege T M, Simpson B R, Goodwin R. Controlled sedation with alphaxalone-alphadolone.  BMJ. 1974;  2 656-659
  • 27 Payen J F, Chanques G, Mantz J et al.. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. 2007 106 687-695 quiz 891-892
  • 28 Brook A D, Ahrens T S, Schaiff R et al.. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation.  Crit Care Med. 1999;  27 2609-2615
  • 29 Costa J, Cabré L, Molina R, Carrasco G. Cost of ICU sedation: comparison of empirical and controlled sedation methods.  Clin Intensive Care. 1994;  5(5, Suppl) 17-21
  • 30 Mascia M F, Koch M, Medicis J J. Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care.  Crit Care Med. 2000;  28 2300-2306
  • 31 Brattebø G, Hofoss D, Flaatten H, Muri A K, Gjerde S, Plsek P E. Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit.  Qual Saf Health Care. 2004;  13 203-205
  • 32 Quenot J P, Ladoire S, Devoucoux F et al.. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia.  Crit Care Med. 2007;  35 2031-2036
  • 33 Arias-Rivera S, Sánchez-Sánchez MdelM, Santos-Díaz R et al.. Effect of a nursing-implemented sedation protocol on weaning outcome.  Crit Care Med. 2008;  36 2054-2060
  • 34 Bucknall T K, Manias E, Presneill J J. A randomized trial of protocol-directed sedation management for mechanical ventilation in an Australian intensive care unit.  Crit Care Med. 2008;  36 1444-1450
  • 35 MacLaren R, Plamondon J M, Ramsay K B, Rocker G M, Patrick W D, Hall R I. A prospective evaluation of empiric versus protocol-based sedation and analgesia.  Pharmacotherapy. 2000;  20 662-672
  • 36 Muller L, Chanques G, Bourgaux C et al.. Impact of the use of propofol remifentanil goal-directed sedation adapted by nurses on the tie to extubation in mechanically ventilated ICU patients: the experience of a French ICU.  Ann Fr Anesth Reanim. 2008;  27 481.e1-e8 , Epub 2008 June 26
  • 37 Elliott R, McKinley S, Aitken L M, Hendrikz J. The effect of an algorithm-based sedation guideline on the duration of mechanical ventilation in an Australian intensive care unit.  Intensive Care Med. 2006;  32 1506-1514
  • 38 De Jonghe B, Bastuji-Garin S, Fangio P et al.. Sedation algorithm in critically ill patients without acute brain injury.  Crit Care Med. 2005;  33 120-127
  • 39 Chanques G, Jaber S, Barbotte E et al.. Impact of systematic evaluation of pain and agitation in an intensive care unit.  Crit Care Med. 2006;  34 1691-1699
  • 40 Kress J P, Pohlman A S, O'Connor M F, Hall J B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.  N Engl J Med. 2000;  342 1471-1477
  • 41 Guldbrand P, Berggren L, Brattebö G, Mälstam J, Rönholm E, Winsö O. Scandinavian Critical Care Trials Group . Survey of routines for sedation of patients on controlled ventilation in Nordic intensive care units.  Acta Anaesthesiol Scand. 2004;  48 944-950
  • 42 Reschreiter H, Maiden M, Kapila A. Sedation practice in the intensive care unit: a UK national survey.  Crit Care. 2008;  12 R152
  • 43 Kress J P, Gehlbach B, Lacy M, Pliskin N, Pohlman A S, Hall J B. The long-term psychological effects of daily sedative interruption on critically ill patients.  Am J Respir Crit Care Med. 2003;  168 1457-1461
  • 44 Girard T D, Kress J P, Fuchs B D et al.. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial.  Lancet. 2008;  371 126-134
  • 45 Wunsch H, Kahn J M, Kramer A A, Rubenfeld G D. Use of intravenous infusion sedation among mechanically ventilated patients in the United States.  Crit Care Med. 2009 Jul 23;  , [Epub ahead of print]
  • 46 Rhoney D H, Murry K R. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.  J Intensive Care Med. 2003;  18 139-145
  • 47 Pandharipande P P, Pun B T, Herr D L et al.. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.  JAMA. 2007;  298 2644-2653
  • 48 Riker R R, Shehabi Y, Bokesch P M SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial.  JAMA. 2009;  301 489-499
  • 49 Ruokonen E, Parviainen I, Jakob S M “Dexmedetomidine for Continuous Sedation” Investigators et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation.  Intensive Care Med. 2009;  35 282-290
  • 50 Patel R P, Gambrell M, Speroff T et al.. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals.  Crit Care Med. 2009;  37 825-832
  • 51 Chamorro C, de Latorre F J, Montero A et al.. Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.  Crit Care Med. 1996;  24 932-939
  • 52 Kress J P, O'Connor M F, Pohlman A S et al.. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam.  Am J Respir Crit Care Med. 1996;  153 1012-1018
  • 53 Weinbroum A A, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.  Intensive Care Med. 1997;  23 1258-1263
  • 54 Sanchez-Izquierdo-Riera J A, Caballero-Cubedo R E, Perez-Vela J L, Ambros-Checa A, Cantalapiedra-Santiago J A, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient.  Anesth Analg. 1998;  86 1219-1224
  • 55 Barrientos-Vega R, Mar Sánchez-Soria M, Morales-García C, Robas-Gómez A, Cuena-Boy R, Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.  Crit Care Med. 1997;  25 33-40
  • 56 Hall R I, Sandham D, Cardinal P Study Investigators et al. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial.  Chest. 2001;  119 1151-1159
  • 57 Carson S S, Kress J P, Rodgers J E et al.. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients.  Crit Care Med. 2006;  34 1326-1332
  • 58 Maldonado J R, Wysong A, van der Starre P J, Block T, Miller C, Reitz B A. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery.  Psychosomatics. 2009;  50 206-217
  • 59 Reade M C, O'Sullivan K, Bates S, Goldsmith D, Ainslie W R, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.  Crit Care. 2009;  13 R75
  • 60 Puntillo K A, White C, Morris A B et al.. Patients' perceptions and responses to procedural pain: results from Thunder Project II.  Am J Crit Care. 2001;  10 238-251
  • 61 Richman P S, Baram D, Varela M, Glass P S. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination.  Crit Care Med. 2006;  34 1395-1401
  • 62 Breen D, Karabinis A, Malbrain M et al.. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].  Crit Care. 2005;  9 R200-R210
  • 63 Muellejans B, López A, Cross M H, Bonome C, Morrison L, Kirkham A J. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713].  Crit Care. 2004;  8 R1-R11
  • 64 Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial.  Crit Care. 2006;  10 R91
  • 65 Rozendaal F W, Spronk P E, Snellen F F UltiSAFE investigators et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands.  Intensive Care Med. 2009;  35 291-298
  • 66 Schweickert W D, Pohlman M C, Pohlman A S et al.. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.  Lancet. 2009;  373 1874-1882

Matthew S KingM.D. 

Department of Pulmonology and Critical Care, Vanderbilt Medical Center

1215 21st Ave. South, Medical Center East, Ste. 6100, Nashville, TN 37232-8300

Email: Matthew.King@Vanderbilt.edu

    >